Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumors
Bones and Joints | Kidney | Soft Tissue | Pediatrics
What is the purpose of this trial?
The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumors.
- Trial withChildren's Oncology Group (COG)
- Start Date01/16/2019
- End Date01/31/2022
- Last Updated01/18/2019
- Study HIC#2000023877